Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis.
Priscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, Sara M Tolaney, Nancy U Lin, Nancy Wang, Ugonma Chukwueke, Michael D White, Naema Nayyar, Albert Kim, Christopher Alvarez-Breckenridge, Ian Krop, Maura Keeley Mahar, Mia S Bertalan, Brian Shaw, Joana L Mora, Nathaniel Goss, Megha Subramanian, Lakshmi Nayak, Jorg Dietrich, Deborah A Forst, Brian V Nahed, Tracy T Batchelor, Helen A Shih, Elizabeth R Gerstner, Beverly Moy, Donald Lawrence, Anita Giobbie-Hurder, Scott L Carter, Kevin Oh, Daniel P Cahill, Ryan J Sullivan
Nature medicine 2020;26(8):1280-1284